Cited by 3,738PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Oncogenic kinase signalling.

Blume-Jensen, Peter, Hunter, Tony·2001·Nature

DOI 10.1038/35077225

Open this paper in CoChat — free account

Abstract

Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans. Their activity is normally tightly controlled and regulated. Perturbation of PTK signalling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation. The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signalling. This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signalling in human malignancies.

Integrity signals

Registry

Crossref · 10.1038/35077225

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Signaling—2000 and Beyond
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Self-citation

Show all 93 references

Research works printed but not linked: 3

Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).
Blume-Jensen, P. & Hunter, T. in Cancer Research - An Encyclopedic Reference (ed. Schwab, M.) (Springer, in the press).
Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).

Sorted by citations

Items 701–800 of 1,008

Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease
Driver, J. A., Zhou, X. Z., & Lu, K. P. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.025 · Cited by 95
Expression of VEGF-A/C, VEGF-R2, PDGF-α/Β, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma
Brunner, M., Thurnher, D., Pammer, J., Geleff, S., Heiduschka, G., Reinisch, C. M., Petzelbauer, P., & Erović, B. M. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.63 · Cited by 92
Targeted therapies in breast cancer: Where are we now?
Cosimo, S. D., & Baselga, J. M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.026 · Cited by 89
Protein Tyrosine Signaling and its Potential Therapeutic Implications in Carcinogenesis
Kim, M., Baek, M., & Kim, D. J. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170616082125 · Cited by 92
Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry
Mnatsakanyan, R., Shema, G., Basik, M., Batist, G., Borchers, C. H., Sickmann, A., & Zahedi, R. P. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1483340 · Cited by 90
Role of heregulin in human cancer
Breuleux, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7120-0 · Cited by 88
A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy
Chen, H., Kovar, J. L., Sissons, S. E., Cox, K. L., Matter, W. F., Chadwell, F., Luan, P., Vlahos, C. J., Schutz-Geschwender, A. R., & Olive, D. M. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.11.015 · Cited by 87
A Single Amino Acid Substitution in the Activation Loop Defines the Decoy Characteristic of VEGFR-1/FLT-1
Meyer, R., Mohammadi, M., & Rahimi, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506454200 · Cited by 86
State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling
Sevecka, M., & MacBeath, G. (2006) · Nature Methods · doi:10.1038/nmeth931 · Cited by 87
Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway
Ong, C.-S., Zhou, J., Ong, C. N., & Shen, H. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.07.001 · Cited by 86
Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model.
Li, H., Velasco-Miguel, S., Vass, W. C., Parada, L. F., & DeClue, J. E. (2002) · PubMed · Cited by 87
Tyrosine kinase inhibitors
Arteaga, C. L., & Baselga, J. M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.028 · Cited by 87
14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).
Liu, M. Y., Cai, S., Espejo, A. B., Bedford, M. T., & Walker, C. L. (2002) · PubMed · Cited by 87
Insulin-like growth factor (IGF) signalling is required for early dorso-anterior development of the zebrafish embryo
Eivers, E., McCarthy, K., Glynn, C., Nolan, C. M., & Byrnes, L. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041913ee · Cited by 87
The Hippo signaling pathway provides novel anti-cancer drug targets
Bae, J. S., Kim, S. M., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.14306 · Cited by 88
Rational design of allosteric modulators: Challenges and successes
Chatzigoulas, A., & Cournia, Z. (2021) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1529 · Cited by 90
Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin
McDonell, L. M., Kernohan, K. D., Boycott, K. M., & Sawyer, S. L. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv254 · Cited by 86
Specific Peptide Ligand for Grb7 Signal Transduction Protein and Pancreatic Cancer Metastasis
Tanaka, S., Pero, S. C., Taguchi, K., Shimada, M., Mori, M., Krag, D. N., & Arii, S. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj105 · Cited by 86
Roles of Stem Cell Factor/c-Kit and Effects of Glivec®/STI571 in Human Uveal Melanoma Cell Tumorigenesis
Lefevre, G. M., Glotin, A., Calipel, A., Mouriaux, F., Tran, T., Kherrouche, Z., Maurage, C., Auclair, C., & Mascarelli, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403907200 · Cited by 86
Structure and Function of the Epidermal Growth Factor (EGF⧸ErbB) Family of Receptors
Leahy, D. J. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)68001-6 · Cited by 86
Integrins and proximal signaling mechanisms in cardiovascular disease
Lal, H. (2009) · Frontiers in bioscience · doi:10.2741/3381 · Cited by 86
c-kit Is Required for Cardiomyocyte Terminal Differentiation
Li, M., Naqvi, N., Yahiro, E., Liu, K., Powell, P. C., Bradley, W. E., Martin, D. I. K., Graham, R. M., Dell’Italia, L. J., & Husain, A. (2008) · Circulation Research · doi:10.1161/circresaha.107.161737 · Cited by 86
Signal Transduction of Oncogenic Flt3
Choudhary, C., Müller‐Tidow, C., Berdel, W. E., & Serve, H. L. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05090 · Cited by 87
Macrophage Proliferation Is Regulated through CSF-1 Receptor Tyrosines 544, 559, and 807
Yu, W., Chen, J., Xiong, Y., Pixley, F. J., Yeung, Y.-G., & Stanley, E. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355610 · Cited by 86
Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines
Guo, D., Ye, J., Dai, J., Li, L.-Z., Chen, F., Ma, D., & Ji, C. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.10.026 · Cited by 86
EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway
Chiu, T. T., Santiskulvong, C., & Rozengurt, E. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00200.2004 · Cited by 86
Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers
Wang, H., Liang, L., Fang, J.-Y., & Xu, J. (2015) · Oncogene · doi:10.1038/onc.2015.304 · Cited by 87
Feedback regulation of RTK signaling in development
Neben, C. L., Lo, M., Jura, N., & Klein, O. D. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.10.017 · Cited by 87
Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem–like Cell Traits in Breast Cancer
Luo, M.-L., Gong, C., Chen, C.-H., Lee, D. Y., Hu, H., Huang, P., Yao, Y., Guo, W., Reinhardt, F., Wulf, G. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2785 · Cited by 87
Protein tyrosine kinase inhibitors: new treatment modalities?
Fabbro, D. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00179-0 · Cited by 86
Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
Ou, X., Gao, G., Habaz, I. A., & Wang, Y. (2024) · MedComm · doi:10.1002/mco2.694 · Cited by 104
Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism.
Yoon, J., Werneburg, N. W., Higuchi, H., Canbay, A. E., Kaufmann, S. H., Akgul, C., Edwards, S. W., & Gores, G. J. (2002) · PubMed · Cited by 83
Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein.
Lekmine, F., Sassano, A., Uddin, S., Smith, J. G., Majchrzak, B., Brachmann, S., Hay, N., Fish, E., & Platanias, L. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.021 · Cited by 99
A Drosophila Model of Multiple Endocrine Neoplasia Type 2
Read, R. D., Goodfellow, P. J., Mardis, E. R., Novak, N., Armstrong, J. R., & Cagan, R. L. (2005) · Genetics · doi:10.1534/genetics.104.038018 · Cited by 84
Chemopreventive Properties of Curcumin
Campbell, F. C., & Collett, G. P. (2005) · Future Oncology · doi:10.1517/14796694.1.3.405 · Cited by 84
MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor
Pan, B., Chan, G. K. Y., Chénard, M., Chi, A., Davis, L. J., Deshmukh, S. V., Gibbs, W. W., Gil, S., Hang, G., Hatch, H., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2541 · Cited by 84
Crosstalk between receptor tyrosine kinases (RTKs) and G protein-coupled receptors (GPCR) in the brain: Focus on heteroreceptor complexes and related functional neurotrophic effects
Liberto, V. D., Mudò, G., & Belluardo, N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.018 · Cited by 87
PI3K/PTEN/AKT Signaling Pathways in Germ Cell Development and Their Involvement in Germ Cell Tumors and Ovarian Dysfunctions
Felici, M. D., & Klinger, F. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189838 · Cited by 83
Medicinal chemistry perspective of pyrido[2,3- d ]pyrimidines as anticancer agents
Kumar, A., Bhagat, K. K., Singh, A. K., Singh, H., Angre, T. D., Verma, A., Khalilullah, H., Jaremko, M., Emwas, A.-H. M., & Kumar, P. (2023) · RSC Advances · doi:10.1039/d3ra00056g · Cited by 85
Application of comparative genomics in the identification and analysis of novel families of membrane-associated receptors in bacteria
Anantharaman, V., & Aravind, L. (2003) · BMC Genomics · doi:10.1186/1471-2164-4-34 · Cited by 83
Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase Calpha.
Zeng, X., Xu, H., & Glazer, R. I. (2002) · PubMed · Cited by 83
Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase
Lee, S., Lin, X., Nam, N., Parang, K., & Sun, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2534493100 · Cited by 83
Bioactive constituents from the green alga Caulerpa racemosa
Yang, P., Liu, D.-Q., Liang, T.-J., Li, J. X., Zhang, H., Liu, A., Guo, Y., & Mao, S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.11.031 · Cited by 83
Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition
Backes, A. C., Zech, B., Felber, B., Klebl, B., & Müller, G. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460440802579975 · Cited by 86
Computational studies of protein regulation by post-translational phosphorylation
Narayanan, A., & Jacobson, M. P. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.02.007 · Cited by 85
Enhanced cell cycle progression and down regulation of p21Cip1/Waf1 by PRL tyrosine phosphatases
Werner, S. R., Lee, P. A., DeCamp, M. W., Crowell, D. N., Randall, S. K., & Crowell, P. L. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00517-2 · Cited by 83
Predominance of activated EGFR higher-order oligomers on the cell surface
Clayton, A. H. A., Orchard, S. G., Nice, E. C., Posner, R. G., & Burgess, A. W. (2008) · Growth Factors · doi:10.1080/08977190802442187 · Cited by 83
Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies
Wong, C., Koh, T.-S., Soo, R. A., Hartono, S., Thng, C. H., McKeegan, E. M., Yong, W. P., Chen, C.-S., Lee, S. C., Wong, J. W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7125 · Cited by 83
Comparison of Kinome Profiles of Barrett's Esophagus with Normal Squamous Esophagus and Normal Gastric Cardia
van Baal, J. W. P. M., Diks, S. H., Wanders, R. J. A., Rygiel, A. M., Milano, F., Joore, J., Bergman, J. J. G. H. M., Peppelenbosch, M. P., & Krishnadath, K. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1370 · Cited by 83
Expression of a Truncated Form of the c-Kit Tyrosine Kinase Receptor and Activation of Src Kinase in Human Prostatic Cancer
Paronetto, M. P., Farini, D., Sammarco, I., Maturo, G., Vespasiani, G., Geremia, R., Rossi, P., & Sette, C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63212-9 · Cited by 85
Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect
Wiese, E. K., & Hitosugi, T. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00079 · Cited by 83
Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer
Xia, H., Xue, X., Ding, H., Ou, Q., Wu, X., Nagasaka, M., Shao, Y. W., Hu, X., & Ou, S. I. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.09.004 · Cited by 87
Overcoming resistance to tyrosine kinase inhibitors: Lessons learned from cancer cells treated with EGFR antagonists
Rexer, B. N., Engelman, J. A., & Arteaga, C. L. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7324 · Cited by 84
Origins, Lineage-Specific Expansions, and Multiple Losses of Tyrosine Kinases in Eukaryotes
Shiu, S., & Li, W. (2004) · Molecular Biology and Evolution · doi:10.1093/molbev/msh077 · Cited by 85
Mass Spectrometry and Site-directed Mutagenesis Identify Several Autophosphorylated Residues Required for the Activity of PrkC, a Ser/Thr Kinase from Bacillus subtilis
Madec, E., Stensballe, A., Kjellström, S., Cladière, L., Obuchowski, M., Jensen, O. N., & Séror, S. J. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00579-5 · Cited by 82
Genomic and proteomic technologies for individualisation and improvement of cancer treatment
Wulfkuhle, J. D., Espina, V. A., Liotta, L. A., & Petricoin, E. F. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.020 · Cited by 83
HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer
Arteaga, C. L., Moulder, S. L., & Yakes, F. M. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70121-8 · Cited by 82
Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells
Zhang, Y., Xu, J., Liu, S., Lim, M., Zhao, S., Cui, K., Zhang, K., Wang, L., Ji, Q., Han, Z., et al. (2019) · Theranostics · doi:10.7150/thno.35305 · Cited by 82
Peptide Inhibitors Targeting Protein Kinases
Eldar-Finkelman, H., & Eisenstein, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682253 · Cited by 82
Phosphoproteomic Analysis Implicates the mTORC2-FoxO1 Axis in VEGF Signaling and Feedback Activation of Receptor Tyrosine Kinases
Zhuang, G., Yu, K., Jiang, Z., Chung, A. S., Yao, J. J., Ha, C., Toy, K. J., Soriano, R. H., Haley, B., Blackwood, E. R., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003572 · Cited by 83
Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis
Kirby, J., Ning, K., Ferraiuolo, L., Heath, P. R., Ismail, A., Kuo, S.-W., Valori, C. F., Cox, L. E., Sharrack, B., Wharton, S. B., et al. (2011) · Brain · doi:10.1093/brain/awq345 · Cited by 81
P38MAPK‐dependent phosphorylation and degradation of SRC‐3/AIB1 and RARα‐mediated transcription
Giannì, M., Parrella, E., Raska, I., Gaillard, E., Nigro, E. A., Gaudon, C., Garattini, E., & Rochette‐Egly, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600981 · Cited by 81
A genetically encoded multifunctional unnatural amino acid for versatile protein manipulations in living cells
Ge, Y., Fan, X., & Chen, P. R. (2016) · Chemical Science · doi:10.1039/c6sc02615j · Cited by 81
Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia
Minami, Y., Yamamoto, K., Kiyoi, H., Ueda, R., Saito, H., & Naoe, T. (2003) · Blood · doi:10.1182/blood-2002-12-3813 · Cited by 81
The Carboxyl Terminus of VEGFR-2 Is Required for PKC-mediated Down-Regulation
Singh, A. J., Meyer, R., Band, H., & Rahimi, N. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0749 · Cited by 81
Protein kinase A phosphorylation characterized by tandem Fourier transform ion cyclotron resonance mass spectrometry
Chalmers, M. J., Håkansson, K., Johnson, R. W., Smith, R. A., Shen, J., Emmett, M. R., & Marshall, A. G. (2004) · PROTEOMICS · doi:10.1002/pmic.200300650 · Cited by 81
Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1α and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway
Jin, H.-O., An, S., Lee, H.-C., Woo, S.-H., Seo, S.-K., Choe, T.-B., Yoo, D.-H., Lee, S.-B., Um, H.-D., & Lee, S.-J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.014 · Cited by 91
Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them
Westerfield, J. M., & Barrera, F. N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.009457 · Cited by 80
Synthesis and Cell-Based Activity of a Potent and Selective Protein Tyrosine Phosphatase 1B Inhibitor Prodrug
Boutselis, I. G., Yu, X., Zhang, Z., & Borch, R. F. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061146x · Cited by 80
Prevention of ovarian cancer: intraepithelial neoplasia.
BREWER, M. A., Johnson, K. A., Follen, M. M., Gershenson, D. M., & Bast, R. C. (2003) · PubMed · Cited by 81
Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
Zhang, J., Sikka, S., Siveen, K. S., Lee, J. H., Um, J., Kumar, A. P., Chinnathambi, A., Alharbi, S. A., Basappa, B., Rangappa, K. S., et al. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1313-7 · Cited by 79
Applications of Infrared Multiple Photon Dissociation (IRMPD) to the Detection of Posttranslational Modifications
Maı̂tre, P., Scuderi, D., Corinti, D., Chiavarino, B., Crestoni, M. E., & Fornarini, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00395 · Cited by 82
Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases
Endres, N., Barros, T. F., Cantor, A. J., & Kuriyan, J. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.08.001 · Cited by 79
Combining Structural Modeling with Ensemble Machine Learning to Accurately Predict Protein Fold Stability and Binding Affinity Effects upon Mutation
Berliner, N., Teyra, J., Çolak, R., Lopez, S. G., & Kim, P. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107353 · Cited by 77
Signal transduction pathways: new targets for treating rheumatoid arthritis
Morel, J., & Berenbaum, F. (2004) · Joint Bone Spine · doi:10.1016/j.jbspin.2004.03.004 · Cited by 81
Phospho‐tyrosine dependent protein–protein interaction network
Großmann, A., Benlasfer, N., Birth, P., Hegele, A., Wachsmuth, F., Apelt, L., & Stelzl, U. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145968 · Cited by 76
A Novel Protein Tyrosine Kinase NOK that Shares Homology with Platelet- Derived Growth Factor/Fibroblast Growth Factor Receptors Induces Tumorigenesis and Metastasis in Nude Mice
Liu, L., Yu, X.-Z., Li, T.-S., Song, L.-X., Chen, P.-L., Suo, T.-L., Li, Y.-H., Wang, S., Chen, Y., Ren, Y.-M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2106 · Cited by 79
Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate.
STRAIR, R. K., Schaar, D. G., Goodell, L. A., Aisner, J., Chin, K., Eid, J. E., Senzon, R., Cui, X. X., Han, Z. T., Knox, B., et al. (2002) · PubMed · Cited by 79
Determinants of Substrate Recognition in Nonreceptor Tyrosine Kinases
Miller, W. T. (2003) · Accounts of Chemical Research · doi:10.1021/ar020116v · Cited by 79
Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions
Burrai, G. P., Mohammed, S. I., Miller, M. A., Marras, V., Pirino, S., Addis, M. F., Uzzau, S., & Antuofermo, E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-156 · Cited by 78
Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis—possible involvement of the EGF receptor
Frušić‐Zlotkin, M., Raichenberg, D., Wang, X., Frušić‐Zlotkin, M., Raichenberg, D., Wang, X., David, M., Michel, B., & Milner, Y. (2006) · Autoimmunity · doi:10.1080/08916930600971836 · Cited by 78
Focal Adhesion Kinase Signaling Regulates Cardiogenesis of Embryonic Stem Cells
Hakuno, D., Takahashi, T., Lammerding, J., & Lee, R. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505575200 · Cited by 79
The G Protein Gα13 Is Required for Growth Factor-Induced Cell Migration
Shan, D., Chen, L., Wang, D., Tan, Y.-C., Gu, J. L., & Huang, X. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.014 · Cited by 78
The Protein Tyrosine Phosphatase TCPTP Suppresses the Tumorigenicity of Glioblastoma Cells Expressing a Mutant Epidermal Growth Factor Receptor
Klingler‐Hoffmann, M., Fodero‐Tavoletti, M. T., Mishima, K., Narita, Y., Cavenee, W. K., Furnari, F. B., Huang, H., & Tiganis, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106571200 · Cited by 78
Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma
Guenther, M. K., Graab, U., & Fulda, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.010 · Cited by 79
Targeting AKT/PKB to improve treatment outcomes for solid tumors
Iida, M., Harari, P. M., Wheeler, D. L., & Toulany, M. (2020) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2020.111690 · Cited by 77
Targeting Krasg12c‐mutant cancer with a mutation‐specific inhibitor
Christensen, J. G., Olson, P., Briere, T., Wiel, C., & Bergö, M. O. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13057 · Cited by 77
Receptor tyrosine kinases and their activation in melanoma
Easty, D. J., Gray, S. G., O'Byrne, K. J., O’Donnell, D., & Bennett, D. C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00836.x · Cited by 79
Features and potentials of ATP-site directed CK2 inhibitors
Sarno, S., Salvi, M., Battistutta, R., Zanotti, G., & Pinna, L. A. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.07.043 · Cited by 77
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
Giordano, C., Catalano, S., Panza, S., Vizza, D., Barone, I., Bonofiglio, D., Gelsomino, L., Rizza, P., Fuqua, S. A. W., & Andò, S. (2011) · Oncogene · doi:10.1038/onc.2011.124 · Cited by 77
Haploinsufficiency of Akt1 Prolongs the Lifespan of Mice
Nojima, A., Yamashita, M., Yoshida, Y., Shimizu, I., Ichimiya, H., Kamimura, N., Kobayashi, Y., Ohta, S., Ishii, N., & Minamino, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069178 · Cited by 78
Ursolic acid induces PC‐3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro
Zhang, Y., Kong, C., Zeng, Y. X., Wang, L., Li, Z., Wang, H., Xu, C., & Sun, Y. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20610 · Cited by 77
Protein Kinases as Targets for Cancer Treatment
Giamas, G., Stebbing, J., Vorgias, C. E., & Knippschild, U. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.8.1005 · Cited by 80
The prolyl isomerase Pin1 in breast development and cancer
Wulf, G. M., Ryo, A., Liou, Y., & Lu, K. P. (2003) · Breast Cancer Research · doi:10.1186/bcr572 · Cited by 78
Cancer proteomics
Tan, H. T., Lee, Y. H., & Chung, M. C. M. (2012) · Mass Spectrometry Reviews · doi:10.1002/mas.20356 · Cited by 77
Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies
Hou, H., & Tien, H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00674-7 · Cited by 86
Functional Nanochannels for Sensing Tyrosine Phosphorylation
Li, M., Xiong, Y., Lü, W., Wang, X., Liu, Y., Na, B., Qin, H., Tang, M., Qin, H., Ye, M., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c06510 · Cited by 76
Treatment of Mice with the Suppressor of Cytokine Signaling-1 Mimetic Peptide, Tyrosine Kinase Inhibitor Peptide, Prevents Development of the Acute Form of Experimental Allergic Encephalomyelitis and Induces Stable Remission in the Chronic Relapsing/Remitting Form
Mujtaba, M. G., Flowers, L. O., Patel, C. B., Patel, R. A., Haider, M. I., & Johnson, H. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5077 · Cited by 77
Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T
Zhao, Y., Zhang, X., Guda, K., Lawrence, E., Qun, S., Watanabe, T., Iwakura, Y., Asano, M., Wei, L., Yang, Z., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914884107 · Cited by 76
Multiple Signaling Pathways Are Responsible for Prostaglandin E2–Induced Murine Keratinocyte Proliferation
Ansari, K. M., Rundhaug, J. E., & Fischer, S. M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2144 · Cited by 76

Authors: Blume-Jensen, P., & Hunter, T.
Affiliations: Salk Institute for Biological Studies (US)
ORCID: Hunter, Tony
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2001-05-01
Volume: 411
Issue: 6835
Pages: 355-365
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/35077225
OpenAlex: W1639582946
Cited by: 3,738
References: 93
Citations by year: 2026: 48 · 2025: 69 · 2024: 87 · 2023: 102 · 2022: 103 · 2021: 114 · 2020: 121 · 2019: 118 · 2018: 105 · 2017: 119 · 2016: 131 · 2015: 156 · 2014: 186 · 2013: 185 · 2012: 200
FWCI: 12.95
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: tyrosine kinase, oncogenic signaling, signal transduction, phosphatidylinositol 3-kinase, Akt, p70 S6 kinase, mTOR, kinase autoinhibition, malignant transformation, human malignancies
MeSH terms: Animals, Humans, Mutation, Neoplasms, Oncogenes, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Retroviridae Proteins, Oncogenic, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, Receptor Protein-Tyrosine Kinases, Oncogene Protein v-akt

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oncogenic kinase signalling.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks